SEC Form 4 research
| Issuer | Attovia Therapeutics, Inc. |
|---|---|
| Tickers | ATTO |
| Reporting owners | 35 |
| Officers and directors | 1 |
| Last public filing | 2026-10-09 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-08 | 2026-08-04 | Fu Tao | A | 538,300 | $0 | Not reported |
| 2026-10-08 | 2026-08-04 | Chan Steven | A | 140,000 | $0 | Not reported |
| 2026-08-28 | 2026-08-06 | WALSH COLIN | P | 500,000 | $17 | Not reported |
| 2026-08-28 | 2026-08-05 | WALSH COLIN | S | 76,418 | $21.04 | Not reported |
| 2026-08-28 | 2026-08-05 | WALSH COLIN | S | 6,763 | $21.61 | Not reported |
| 2026-08-28 | 2026-08-05 | WALSH COLIN | S | 100 | $21.99 | Not reported |
| 2026-08-28 | 2026-08-05 | WALSH COLIN | S | 1,163 | $22.19 | Not reported |
| 2026-08-28 | 2026-08-05 | WALSH COLIN | S | 700 | $22.07 | Not reported |
| 2026-08-28 | 2026-08-05 | WALSH COLIN | S | 200 | $22.05 | Not reported |
| 2026-08-28 | 2026-08-05 | WALSH COLIN | S | 443 | $21.78 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.